High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 363-377

  Cui, Yanfen ^a   Yang, Shaobin ^a   Fu, Xin ^a   Feng, Jingwen ^a   Xu, Shilei ^a   Ying, Guoguang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

KAP1; Ovarian cancer; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; KRAB ASSOCIATED PROTEIN 1; PROTEIN; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; REPRESSOR PROTEIN; TRIM28 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL MIGRATION; COLLOID CARCINOMA; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING; WOUND HEALING; AGED; CARCINOMA; CASE CONTROL STUDY; GENETICS; METABOLISM; OVARIAN NEOPLASMS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; REPRESSOR PROTEINS;

EID: 84919918762     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16010363     Document Type: Article

References (26)

1. Coleman, M.P.; Forman, D.; Bryant, H.; Butler, J.; Rachet, B.; Maringe, C.; Nur, U.; Tracey, E.; Coory, M.; Hatcher, J.; et al,. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011, 377, 127–138.
2. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63, 11–30.
3. Wang, B.; Liu, S.Z.; Zheng, R.S.; Zhang, F.; Chen, W.Q.; Sun, X.B. Time trends of ovarian cancer incidence in china. Asian Pac. J. Cancer Prev. 2014, 15, 191–193.
4. Haruta, S.; Furukawa, N.; Yoshizawa, Y.; Tsunemi, T.; Nagai, A.; Kawaguchi, R.; Tanase, Y.; Yoshida, S.; Kobayashi, H. Molecular genetics and epidemiology of epithelial ovarian cancer (Review). Oncol. Rep. 2011, 26, 1347–1356.
5. Xu, L.; Cai, J.; Yang, Q.; Ding, H.; Wu, L.; Li, T.; Wang, Z. Prognostic significance of several biomarkers in epithelial ovarian cancer: A meta-analysis of published studies. J. Cancer Res. Clin. Oncol. 2013, 139, 1257–1277.
6. Reade, C.J.; Riva, J.J.; Busse, J.W.; Goldsmith, C.H.; Elit, L. Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis. Gynecol. Oncol. 2013, 130, 674–681.
7. Friedman, J.R.; Fredericks, W.J.; Jensen, D.E.; Speicher, D.W.; Huang, X.P.; Neilson, E.G.; Rauscher, F.J. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 1996, 10, 2067–2078.
8. Messerschmidt, D.M.; de Vries, W.; Ito, M.; Solter, D.; Ferguson-Smith, A.; Knowles, B.B. Trim28 is required for epigenetic stability during mouse oocyte to embryo transition. Science 2012, 335, 1499–1502.
9. Shibata, M.; Blauvelt, K.E.; Liem, K.F., Jr.; García-García, M.J. TRIM28 is required by the mouse KRAB domain protein ZFP568 to control convergent extension and morphogenesis of extra-embryonic tissues. Development 2011. 138, 5333–5343.
10. Rowe, H.M.; Jakobsson, J.; Mesnard, D.; Rougemont, J.; Reynard, S.; Aktas, T.; Maillard, P.V.; Layard-Liesching, H.; Verp, S.; Marquis, J.; et al,. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 2010, 463, 237–240.
11. White, D.E.; Negorev, D.; Peng, H.; Ivanov, A.V.; Maul, G.G.; Rauscher, F.J., III. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res. 2006, 66, 11594–11599.
12. White, D.; Rafalska-Metcalf, I.U.; Ivanov, A.V.; Corsinotti, A.; Peng, H.; Lee, S.C.; Trono, D.; Janicki, S.M.; Rauscher, F.J., III. The ATM substrate KAP1 controls DNA repair inheterochromatin: regulation by HP1 proteins and serine 473/824 phosphorylation. Mol. Cancer Res. 2012. 10, 401–414.
13. Groner, A.C.; Meylan, S.; Ciuffi, A.; Zangger, N.; Ambrosini, G.; Dénervaud, N.; Bucher, P.; Trono, D. KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet. 2010, 6, doi:10.1371/journal.pgen.1000869.
14. Xiao, T.Z.; Bhatia, N.; Urrutia, R.; Lomberk, G.A.; Simpson, A.; Longley, B.J. MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression. PLoS One 2011, 6, e23747.
15. Venkov, C.D.; Link, A.J.; Jennings, J.L.; Plieth, D.; Inoue, T.; Nagai, K.; Xu, C.; Dimitrova, Y.N.; Rauscher, F.J., III; Neilson, E.G. A proximal activator of transcription in epithelial-mesenchymal transition. J. Clin. Investig. 2007, 117, 482–491.
16. Cai, M.; Hu, Z.; Liu, J.; Gao, J.; Liu, C.; Liu, D.; Tan, M.; Zhang, D.; Lin, B. Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int. J. Mol. Sci. 2014, 15, 5292–5303.
17. Kebebew, E.; Peng, M.; Reiff, E.; McMillan, A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006, 106, 2592–2597.
18. Yokoe, T.; Toiyama, Y.; Okugawa, Y.; Tanaka, K.; Ohi, M.; Inoue, Y.; Mohri, Y.; Miki, C.; Kusunoki, M. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann. Surg. Oncol. 2010, 17, 821–828.
19. Wang, Y.Y.; Li, L.; Zhao, Z.S.; Wang, H.J. Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer. World J. Surg. Oncol. 2013, 11, 81.
20. Varghese, S.; Burness, M.; Xu, H.; Beresnev, T.; Pingpank, J.; Alexander, H.R. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann. Surg. Oncol. 2007, 14, 3460–3471.
21. Jeffery, N.; McLean, M.H.; el-Omar, E.M.; Murray, G.I. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology 2009, 54, 820–828.
22. Liu, L.; Zhao, E.; Li, C.; Huang, L.; Xiao, L.; Cheng, L.; Huang, X.; Song, Y.; Xu, D. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer Epidemiol. 2013, 37, 71–78.
23. Chen, L.; Chen, D.T.; Kurtyka, C.; Rawal, B.; Fulp, W.J.; Haura, E.B.; Cress, W.D. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J. Biol. Chem. 2012, 287, 40106–40118.
24. Liu, J.; Welm, B.; Boucher, K.M.; Ebbert, M.T.W.; Bernard, P.S. TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. Am. J. Pathol. 2012, 180, 839–847.
25. Lee, Y.K.; Thomas, S.N.; Yang, A.J.; Ann, D.K. Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J. Biol. Chem. 2007, 282, 1595–1606.
26. Okamoto, K.; Kitabayashi,I.; Taya,Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem. Biophys. Res. Commun. 2006, 351, 216–222.